AstraZeneca PLC (OTCMKTS:AZNCF) Short Interest Up 157.8% in April

AstraZeneca PLC (OTCMKTS:AZNCF) was the target of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 174,800 shares, a growth of 157.8% from the March 31st total of 67,800 shares. Based on an average trading volume of 2,200 shares, the short-interest ratio is currently 79.5 days.

AstraZeneca Price Performance

Shares of AZNCF stock traded down $0.95 during trading hours on Friday, reaching $145.10. 55,915 shares of the company’s stock were exchanged, compared to its average volume of 3,606. The stock’s fifty day moving average price is $133.52 and its two-hundred day moving average price is $131.07. AstraZeneca has a 1 year low of $118.16 and a 1 year high of $152.06.

AstraZeneca Increases Dividend

The business also recently declared a dividend, which was paid on Monday, March 25th. Shareholders of record on Friday, February 23rd were given a $1.97 dividend. The ex-dividend date of this dividend was Wednesday, February 21st. This is a positive change from AstraZeneca’s previous dividend of $0.93. AstraZeneca’s dividend payout ratio (DPR) is currently 343.14%.

AstraZeneca Company Profile

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.